Figure 7
From: Real time in vitro studies of doxorubicin release from PHEMA nanoparticles
Effect of initiator [Bz 2 O 2 ]. Effect of initiator [Bz2O2] content on the (a) swelling profile and (b) release profile of the nanoparticles of definite composition, [HEMA] = 12.37 mM, [EGDMA] = 1.06 mM, % loading = 28%, pH = 7.4, temp. = 37°C.